Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zuliani G is active.

Publication


Featured researches published by Zuliani G.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1993

Pregnancy at forty and over: a case-control study.

Paolo Vercellini; Zuliani G; Maria Teresa Rognoni; Laura Trespidi; Sabina Oldani; Anna Cardinale

We compared obstetric prognosis in 327 women > or = 40 years old (148 nulliparas, 279 multiparas) with 20-30-year-old matched controls who delivered at our department between 1988 and 1990. Gestational diabetes and chronic hypertension were the only more frequent antepartum complications in cases than controls (2.4% vs. 0.3% and 3.4% vs. 0.3%, respectively). There were more premature deliveries in cases than controls (19% vs. 8%) but no difference in postdate deliveries. Cesarean section was more frequent in cases than controls in both nulliparas (64% vs. 30%) and multiparas (43% vs. 12%). Incidence of abdominal delivery for acute obstetrical indications was not increased in older gravidas. Significant differences were observed in low birthweight (17% vs. 5%) and 5-min Apgar score < 7 (8% vs. 2%). Most of the abnormal Apgar scores were recorded after cesarean section; values for vaginally-delivered infants were comparable in older and younger women. Perinatal mortality was similar in the two groups.


Fetal Diagnosis and Therapy | 1995

Changes in Blood Flow Velocity Waveforms following Fetal Blood Sampling

Cinzia Zoppini; Diana Brioschi; Beatrice Tassis; Zuliani G; Alessandra Kustermann; Umberto Nicolini

The umbilical artery, aorta, and middle cerebral artery pulsatility indices were investigated by pulsed Doppler ultrasound in 73 fetuses at 18-37 weeks of gestation, before and after fetal blood sampling performed either at the placental cord insertion (n = 46) or at the intrahepatic vein (n = 27). At the end of the procedure, after randomization, 35 fetuses were infused amounts of normal saline equal to the blood volume withdrawn, and 38 fetuses served as controls. Following blood sampling, the umbilical artery pulsatility indices decreased both in controls (p = 0.004) and in the saline group (p = 0.006). The middle cerebral artery velocity waveforms exhibited similar changes only in controls (p = 0.01), and no changes in fetal heart rate and aortic pulsatility indices were recorded in either group. The changes in blood flow velocity waveforms did not correlate with gestational age and the blood volume sampled, and were similar whether the site of sampling was the placental cord insertion or the intrahepatic vein. In 10 acidemic and/or hypoxemic fetuses, pulsatility indices in the umbilical and middle cerebral arteries were not modified by the blood sampling procedure. The release of vasoactive substances is most likely the cause of diminished vascular resistances following fetal blood sampling. Hypoxemic/acidemic fetuses may fail to mount a normal vasodilative response to needle puncture.


La Ricerca in Clinica E in Laboratorio | 1983

Hemolytic disease of the newborn due to rare alloantibodies

Zuliani G; Gian Alessandro Moroni; Mauro Buscaglia; Raffaella Morotti; Giorgio Pardi

SummaryIn the period January 1975 to December 1981, serum sampies from 9,525 pregnant women were examined for irregular red cell antibodies. Red cell, antibodies were found in 719 cases (7.5%); anti D antibodies were present in 532 cases (5.5% of the whole series), rare antibodies (other than anti-D) in 187 cases (2%). Seven pregnant women with rare red cell antibodies were followed at our Institute up to delivery. The clinical management, which was based on the diagnostic and therapeutic procedures of hemolytic disease of newborn due to anti-D antibodies, is reported in detail. The findings underline the importance of careful screening for irregular red cell antibodies in all pregnant women, both Rh-negative and Rh-positive, and confirm the validity of Rh clinical management also for moderate or severe immunizations due to rare red cell antibodies.


Fetal Diagnosis and Therapy | 2018

Risk of Fetal Loss in Pregnancies Undergoing Midtrimester Amniocentesis after Inconclusive Chorionic Villus Sampling

G. Salsi; Francesca Romana Grati; F. Bellussi; Eva Pompilii; Federico Maggi; Giuseppe Simoni; Francesco D’Ambrosi; Michele Orsi; Mattia Gentile; G. Rembouskos; Zuliani G; P. Volpe; G. Pilu

Objective: To estimate the procedure-related risk of miscarriage in pregnancies undergoing amniocentesis (AC) following inconclusive results for a chorionic villus sampling (CVS). Methods: This was a multicentric retrospective cohort study of patients in which both CVS at 11–13 weeks’ gestation and AC at 16–22 weeks were performed between January 1st, 2008, and July 31st, 2017. The primary outcome measure was pregnancy loss prior to 24 weeks gestation; the secondary one was intrauterine demise after 24 weeks. Results: A total of 287 patients underwent transabdominal CVS and AC. Nine patients were lost at follow-up; therefore, the analysis was conducted on a population of 278 patients (275 singletons and 3 dichorionic twin pregnancies). AC was performed because of placental mosaicism (93.6%), failure of direct/semidirect preparation of trophoblastic cells (3.2%), or targeted genetic testing after the diagnosis of an anomaly in the second trimester (3.2%). In continuing pregnancies, there were no fetal losses prior to 24 weeks’ gestation. Two intrauterine demises (including 1 fetus with multiple anomalies and growth restriction) in the third trimester were recorded. Conclusion: Patients undergoing midtrimester AC because of an inconclusive result of CVS can be reasonably reassured that in general the risk of miscarriage and fetal loss following the procedure is very small.


The Lancet | 1999

Alcohol injection: A new method of treating placental chorioangiomas

Umberto Nicolini; Zuliani G; Elena Caravelli; Roberto Fogliani; Andres Poblete; Alistair Roberts


Obstetrics & Gynecology | 1996

Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling

Simona Nava; Luisa Bocconi; Zuliani G; Alessandra Kustermann; Umberto Nicolini


European Journal of Immunology | 1989

Terminal deoxynucleotidyl transferase‐positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues

Giorgio Cattoretti; Carlo Parravicini; Antonio Bonati; Mauro Buscaglia; Zuliani G; Anna Plebani; Domenico Delia; Franco Rilke


Annali di ostetricia, ginecologia, medicina perinatale | 1990

[Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].

Tantalo; Rossi E; Gianotti Ga; Morotti R; Zuliani G; Mauro Buscaglia; Galligani M


Annali di ostetricia, ginecologia, medicina perinatale | 1984

[Use of a clindamycin phosphate-gentamycin combination in endometritis following induced abortion].

Rossi P; Zuliani G; Mauro Buscaglia; Pardi G


Annali di ostetricia, ginecologia, medicina perinatale | 1990

[Twin pregnancy with acephalic acardiac fetus. Anatomo-clinical description of 2 cases].

Sanchioni L; Presti C; Morotti R; Zuliani G; Alessandra Kustermann; Mauro Buscaglia; Gandini S

Collaboration


Dive into the Zuliani G's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alessandra Kustermann

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge